Luyan Pharma Co.,Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 8,474.180 million compared to CNY 7,214.832 million a year ago. Operating income was CNY 201.115 million compared to CNY 181.762 million a year ago. Net income was CNY 153.140 million compared to CNY 130.029 million a year ago. Basic earnings per share from continuing operations was CNY 0.39 compared to CNY 0.37 a year ago.